GlassScriptPhysician profile
Jacob Joseph
NPI 1841551090
$88,573.45
in general payments reported to CMS, 2019-2025
10 companies · $1,562 in 2025
The $1,562 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76K · 2020: $845 · 2021: $25.96 · 2022: $926 · 2023: $1,387 · 2024: $7,552 · 2025: $1,562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,400 · Travel and Lodging: $2,800 · Food and Beverage: $1,301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,400.00 |
| Travel and Lodging | $2,799.91 |
| Food and Beverage | $1,300.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $75,041.37 | 2019 | |
| Globus Medical, INC. | $12,144.30 | 2019-2025 | Xlif, Excelsius Gps, Mars 3v/3vl |
| Stryker Corporation | $535.36 | 2024 | |
| Medtronic, INC. | $468.90 | 2021-2025 | Clydesdale Ptc Spinal System, Mazor X System, Unid_pass |
| Titan Spine, LLC | $134.01 | 2019 | |
| Si-Bone, INC. | $86.42 | 2019 | |
| Cerapedics INC. | $80.82 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Integra Lifesciences Corporation | $52.58 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.06 | 2019 | |
| Medtronic USA, INC. | $13.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.